Plasticell Funding: How Much Did They Raise & Key Investors

How Much Did Plasticell Raise?
Funding & Key Investors

Plasticell, a pioneer in the field of regenerative medicine, has successfully secured a total capital infusion of $2.7M to advance its proprietary therapeutic platforms. This trajectory of financial backing, which includes a recent strategic investment of $1.9M, underscores the company's enduring commitment to transforming stem cell research into viable clinical applications. By leveraging its award-winning combinatorial screening technology, the firm continues to attract significant interest from both governmental bodies and private equity stakeholders, solidifying its position within the competitive United Kingdom life sciences landscape.

The company's growth narrative is defined by a long-term commitment to precision medicine, moving from early-stage research initiatives to a more mature enterprise-level operational model. This latest injection of capital serves as a critical catalyst for scaling its therapeutic pipeline and refining its proprietary cell manipulation techniques.

What is Plasticell?

Plasticell

Business Services

Research & Development

Founded in 2002 and headquartered in Stevenage, Hertfordshire, Plasticell operates at the intersection of biotechnology and advanced cell therapy. The company specializes in the precise manipulation of stem cells and differentiated cell types, utilizing its unique combinatorial screening technology to identify optimal conditions for cell differentiation and expansion. This technological edge allows Plasticell to address complex challenges in drug discovery and regenerative medicine, positioning it as a key player in the development of next-generation therapeutic interventions. By maintaining a focus on high-throughput screening, the company effectively bridges the gap between fundamental biological research and commercial-scale therapeutic manufacturing.

How much funding has Plasticell raised?

Plasticell has raised a total of $2.7M across 2 funding rounds:

2007

Other Financing Round

$774K

2021

Private Equity

$1.9M

Other Financing Round (2007): $774K with participation from Department of Trade & Industry and Innovate UK

Private Equity (2021): $1.9M, investors not publicly disclosed

Key Investors in Plasticell

Department of Trade & Industry

A government body focused on fostering industrial growth and supporting the development of innovative technologies within the United Kingdom.

Innovate UK

A non-departmental public body that provides funding and support to businesses and research organizations to drive innovation and economic growth.

Undisclosed Investor

An undisclosed institutional investor participating in the latest private equity round to support the company's strategic scaling efforts.

What's next for Plasticell?

With the recent strategic investment, Plasticell is well-positioned to accelerate its clinical development programs and expand its intellectual property portfolio. The company is expected to focus on scaling its combinatorial screening platform to address a broader range of therapeutic indications, potentially entering into new collaborative partnerships with global pharmaceutical entities. As the firm transitions into this next phase of growth, the emphasis will likely shift toward regulatory milestones and the validation of its lead candidates in human trials, ensuring that its innovative approach to stem cell manipulation translates into tangible patient outcomes and long-term enterprise value.

See full Plasticell company page

See More Financial Insights